新型口服抗凝剂治疗椎动脉夹层一例报告。

Fernando Góngora-Rivera, Héctor R Martínez, Leonel Cantu-Martinez, Carlos R Camara-Lemarroy, Talía Moreno-Andrade
{"title":"新型口服抗凝剂治疗椎动脉夹层一例报告。","authors":"Fernando Góngora-Rivera,&nbsp;Héctor R Martínez,&nbsp;Leonel Cantu-Martinez,&nbsp;Carlos R Camara-Lemarroy,&nbsp;Talía Moreno-Andrade","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Cervical artery dissections, which may be traumatic or spontaneous, account for a significant proportion of strokes in the young. Antithrombotic therapy is the mainstay of treatment, but new oral anticoagulants could be an alternative treatment to the optimal strategy of anticoagulation followed by antiplatelet drugs.</p><p><strong>Summary of case: </strong>We report the case of a 40-year-old patient with a spontaneous vertebral artery dissection who developed a cerebellar ischemic stroke, who had a favorable outcome and complete vessel recanalization after three months of treatment with the oral factor Xa inhibitor rivaroxaban.</p><p><strong>Conclusion: </strong>New oral anticoagulant could constitute an alternative and new therapeutic option in cervical artery dissections.</p>","PeriodicalId":88555,"journal":{"name":"Journal of vascular and interventional neurology","volume":"10 2","pages":"56-58"},"PeriodicalIF":0.0000,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350868/pdf/jvin-10-2-12.pdf","citationCount":"0","resultStr":"{\"title\":\"Novel Oral Anticoagulants as Treatment for Vertebral Artery Dissection: Case Report.\",\"authors\":\"Fernando Góngora-Rivera,&nbsp;Héctor R Martínez,&nbsp;Leonel Cantu-Martinez,&nbsp;Carlos R Camara-Lemarroy,&nbsp;Talía Moreno-Andrade\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and purpose: </strong>Cervical artery dissections, which may be traumatic or spontaneous, account for a significant proportion of strokes in the young. Antithrombotic therapy is the mainstay of treatment, but new oral anticoagulants could be an alternative treatment to the optimal strategy of anticoagulation followed by antiplatelet drugs.</p><p><strong>Summary of case: </strong>We report the case of a 40-year-old patient with a spontaneous vertebral artery dissection who developed a cerebellar ischemic stroke, who had a favorable outcome and complete vessel recanalization after three months of treatment with the oral factor Xa inhibitor rivaroxaban.</p><p><strong>Conclusion: </strong>New oral anticoagulant could constitute an alternative and new therapeutic option in cervical artery dissections.</p>\",\"PeriodicalId\":88555,\"journal\":{\"name\":\"Journal of vascular and interventional neurology\",\"volume\":\"10 2\",\"pages\":\"56-58\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350868/pdf/jvin-10-2-12.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of vascular and interventional neurology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of vascular and interventional neurology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景和目的:颈动脉夹层可能是外伤性的,也可能是自发性的,在年轻人中风中占很大比例。抗血栓治疗是治疗的主要手段,但新的口服抗凝剂可能是抗凝后抗血小板药物的最佳策略的替代治疗。病例总结:我们报告了一例40岁的自发性椎动脉解剖患者并发小脑缺血性中风,经口服Xa因子抑制剂利伐沙班治疗三个月后,患者预后良好,血管完全再通。结论:新型口服抗凝剂可作为治疗颈动脉夹层的一种新方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Novel Oral Anticoagulants as Treatment for Vertebral Artery Dissection: Case Report.

Novel Oral Anticoagulants as Treatment for Vertebral Artery Dissection: Case Report.

Background and purpose: Cervical artery dissections, which may be traumatic or spontaneous, account for a significant proportion of strokes in the young. Antithrombotic therapy is the mainstay of treatment, but new oral anticoagulants could be an alternative treatment to the optimal strategy of anticoagulation followed by antiplatelet drugs.

Summary of case: We report the case of a 40-year-old patient with a spontaneous vertebral artery dissection who developed a cerebellar ischemic stroke, who had a favorable outcome and complete vessel recanalization after three months of treatment with the oral factor Xa inhibitor rivaroxaban.

Conclusion: New oral anticoagulant could constitute an alternative and new therapeutic option in cervical artery dissections.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信